Related Experiment Video
Updated: Feb 12, 2026

Studying the Role of Alveolar Macrophages in Breast Cancer Metastasis
Published on: June 26, 2016
SIRT1 and microRNAs: The role in breast, lung and prostate cancers
Hedyieh Karbasforooshan1, Ali Roohbakhsh2, Gholamreza Karimi2
1Faculty of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.
Abstract:
Breast cancer and prostate cancer are the most common malignant tumors in female and men, respectively. Furthermore, lung cancer is the leading cause of cancer deaths worldwide. It is an emergency to develop a powerful strategy to treat these threatening cancers more effectively, because of low efficacy and high rates of chemotherapy effects. MicroRNAs (miRNAs), a class of small non-coding RNAs, are key regulators of gene expression via induction of translational repression or mRNA degradation. MiRNA deregulation has been linked to cancer initiation and progression. Silent Inflammation Regulator 2 (SIR2) proteins-sirtuins- are a family of histone deacetylases (HDACs) that catalyze deacetylation of both histone and non- histone lysine residues. SIRT1 can act as an oncogene. It plays a role in tumorigenesis by anti-apoptotic activity and is implicated in diverse cellular process including autophagy, senescence, apoptosis, proliferation, and aging. MicroRNAs and SIRT1 serve as tumor suppressors or tumor promotors depending on the oncogenic pathway specific to particular tumors. MicroRNAs modulate cancer development by targeting SIRT1. In this review, we underlie the specific mechanisms involved in these threatening cancers by microRNAs/SIRT1 pathways.
Insights
MicroRNAs and SIRT1 play crucial roles in breast, prostate, and lung cancers. Understanding their complex interactions offers new therapeutic strategies for these widespread diseases.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- Breast, prostate, and lung cancers are leading causes of mortality worldwide, necessitating improved treatment strategies due to chemotherapy limitations.
- MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression and are implicated in cancer development.
- Sirtuins, specifically SIRT1, are histone deacetylases involved in tumorigenesis through various cellular processes, acting as either oncogenes or tumor suppressors.
Purpose of the Study:
- To review the specific mechanisms by which microRNAs and SIRT1 pathways influence the development of breast, prostate, and lung cancers.
- To elucidate the dual role of microRNAs and SIRT1 as either tumor suppressors or promoters based on specific oncogenic pathways.
- To highlight the potential of targeting microRNA/SIRT1 interactions for novel cancer therapies.
Main Methods:
- Literature review focusing on the molecular mechanisms of microRNA and SIRT1 involvement in cancer.
- Analysis of studies detailing how microRNAs target SIRT1 in various cancer types.
- Synthesis of information on the regulatory roles of microRNAs and SIRT1 in tumorigenesis.
Main Results:
- MiRNA deregulation is a significant factor in cancer initiation and progression.
- SIRT1 can function as an oncogene, promoting tumorigenesis through anti-apoptotic activities and influencing cellular processes like proliferation and senescence.
- MicroRNAs modulate cancer development by directly targeting SIRT1, influencing its oncogenic or tumor-suppressive functions.
Conclusions:
- The interplay between microRNAs and SIRT1 is critical in the pathogenesis of major cancers, including breast, prostate, and lung cancer.
- Targeting the microRNA/SIRT1 axis presents a promising avenue for developing more effective cancer treatments.
- Further research into these specific pathways could lead to personalized therapeutic approaches for cancer patients.
Related Concept Videos
MicroRNAs
MicroRNAs
Lung Capacity
Role of Septins
Cellular Functions of Septins
Recent studies have revealed the multifaceted roles of septins in various cellular processes such as cytokinesis, ciliogenesis, and neurogenesis. Septins act as scaffolds and...
The Role of Culture
Role-Based Identity

